Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2003
03/20/2003WO2002026932A9 Rna aptamers and methods for identifying the same
03/20/2003WO2002024897A9 Conditionally replicating viral vectors and their use
03/20/2003WO2002024884A3 Regulation of human serine palmitoyltransferase-like enzyme
03/20/2003WO2002022809A9 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
03/20/2003WO2002022667A9 Twin-arginine translocation in bacillus
03/20/2003WO2002020748A3 Host cells for packing a recombinant adeno-associated virus (raav), method for the production and use thereof
03/20/2003WO2002020736A3 Proteases
03/20/2003WO2002020718A9 Osteoclast-associated receptor
03/20/2003WO2002018635A3 Use of nonviable particles comprising an internal control (ic) nucleic acid
03/20/2003WO2002018620A3 Neutrokine-alpha and neutrokine-alpha splice variant
03/20/2003WO2002017947A3 Use of t proteins for the differential characterization and treatment of lesions and tumors of the nervous system
03/20/2003WO2002014551A3 Bioluminescent methods for direct visual detection of environmental compounds
03/20/2003WO2002009641A9 Promyostatin peptides and methods of using same
03/20/2003WO2002006312A3 Disease-associated gene
03/20/2003WO2002004619A3 Dehydroquinate dehydrase/shikimate dehydrogenase as a herbicide target
03/20/2003WO2002004520A3 Transporters and ion channels
03/20/2003WO2002004490A3 Lipid metabolism molecules
03/20/2003WO2002002811A3 Method for controlling the microbiological quality of an aqueous medium and kit therefor
03/20/2003WO2001092579A3 Methods for detecting target nucleic acids using coupled ligation and amplification
03/20/2003WO2001079420A3 Detection and amplification or rna using target-mediated ligation of dna by rna ligase
03/20/2003WO2001078894A3 Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease
03/20/2003WO2001075180A3 Sequence-dependent gene sorting techniques
03/20/2003WO2001072341A3 Methods of treating neoplasia with combinations of target cell-specific adenovirus, chemotherapy and radiation
03/20/2003WO2001070253A8 Use of mia in immunotherapy
03/20/2003WO1999049294A3 Assay methods
03/20/2003US20030056249 Nucleotide sequences coding polypeptides for use in the generation of disease and stress resistant plants
03/20/2003US20030056248 Heat stable mutants of starch biosynthesis enzymes
03/20/2003US20030056247 Transcription factor for use in controlling flowering in plants
03/20/2003US20030056246 Selective modification of plant fatty acids
03/20/2003US20030056245 AP1 amine oxidase variants
03/20/2003US20030056244 Feed additive compositions and methods
03/20/2003US20030056243 Trangenic plant seed mixture for classfication of preferential seeds
03/20/2003US20030056242 Nucleotide sequences coding polypeptide for use in the generation of threonine and lysine for human and animal foods
03/20/2003US20030056241 Chicken leukemia inhibitory factor (LIF) and gene thereof
03/20/2003US20030056240 Transgenic animal model for use in the treatment of diabetes
03/20/2003US20030056239 NMP35 apoptosis inhibitor gene disruptions, compositions and methods related thereto
03/20/2003US20030056238 GABA B1A receptor disruptions, compositions and methods relating thereto
03/20/2003US20030056237 Production of ungulates, preferably bovines that produce human immunoglobulins
03/20/2003US20030056236 Model
03/20/2003US20030056235 Inhibition of gene expression in cells; obtain celss, transform with ribonucleic acids, monitor and detect adjustment in gene expression, adjustment in gene expression indicates gene expression inhibition
03/20/2003US20030056234 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of myocardial infarction, atherosclerosis and cardiovascular disorders
03/20/2003US20030056232 Animal showing schizophrenia-like abnormality in cognitive behaviors and method of constructing the same
03/20/2003US20030056231 Development of transgenic model for interventions in neurodegenerative diseases
03/20/2003US20030056230 Directs expression of the steroid receptor gene in the epithelium in the non-human animal; transgenic animals are useful in screening drugs and treatments designed to target hormone receptors and other proteins
03/20/2003US20030056229 Nucleotide sequences coding polypeptide for use in the treatment of leukemias, autoimmune and arthritic diseases
03/20/2003US20030055257 Water-soluble rhodamine dye conjugates
03/20/2003US20030055243 Atropisomers of asymmetric xanthene fluorescent dyes and methods of DNA sequencing and fragment analysis
03/20/2003US20030055241 Processes of purifying oligonucleotides
03/20/2003US20030055240 HPV specific oligonucleotides
03/20/2003US20030055239 Human receptor tyrosine kinase, KDR
03/20/2003US20030055238 Nucleotide sequences coding polypeptide for use in the treatment of schizophrenia, parkinson's, drug addiction and eating disorders
03/20/2003US20030055236 Secreted protein HKABT24
03/20/2003US20030055232 Nucleotide sequences coding enzymatic polypeptide for use in the generation of lysine
03/20/2003US20030055223 Monoclonal antibodies to antigens expressed by hematopoietic facilitatory cells
03/20/2003US20030055220 Protein complex for use in the diagnosis and prevention of bacterial infections
03/20/2003US20030055218 Human receptor proteins; related reagents and methods
03/20/2003US20030055217 Peptides derived from STEAP1
03/20/2003US20030055215 Calcium-binding protein for use in the treatment of inflammation, tumors and skin disorders
03/20/2003US20030055020 Introducing ribonucleic acid (RNA) into cell in an amount sufficient to inhibit expression of target gene, wherein RNA comprises a double-stranded structure with an identical nucleotide sequence as compared to portion of target gene
03/20/2003US20030055019 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity
03/20/2003US20030055018 Abrogating GTPase(Guanosine Triphosphatase)-Responsive Domain in p85 subunit of the PI3K for modulating phosphoinositide 3-kinase (PI3K) activity or phosphatidylinositol-3,4,5-P3 (PIP3) production
03/20/2003US20030055017 Gene therapy
03/20/2003US20030055015 Therapy and prophylaxis of diseases
03/20/2003US20030055006 Combinations and compositions which interfere with VEGF/VEGF and angiopoietin/tie receptor function and their use
03/20/2003US20030054997 OB protein compositions and methods
03/20/2003US20030054996 Contacting complex comprising a GRP94 protein with a binding agent that is immobilized to a solid phase support, to immobilize the complex to solid phase support; collecting the remaining sample; eluting the complex from solid phase support
03/20/2003US20030054994 Apoptosis inducing proteinaceous substance
03/20/2003US20030054993 For contraception in a mammal, for therapy of infertility
03/20/2003US20030054992 Therapy
03/20/2003US20030054990 Methods of using neural thread proteins to treat tumors and other conditions requiring the removal or destruction of cells
03/20/2003US20030054987 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054555 Generation of adenoviral vectors; obtain nucleotide sequences, incubate with vector, expose to recombinases, recover vector
03/20/2003US20030054554 Albumin derivatives with therapeutic functions
03/20/2003US20030054553 Transgenic cell for the propagation of adenoviral vectors
03/20/2003US20030054552 Vector for use in the propagation and cloning of preferential nucleotide nucleotide sequences
03/20/2003US20030054548 Lentiviral packaging constructs
03/20/2003US20030054547 Polyketide synthase gene from sorangium cellulosum
03/20/2003US20030054539 Enzymatic polypeptide for use in paper making, detergents and textile processing
03/20/2003US20030054537 Genetically engineered bacteria for use as tools in the generation of heterologous proteins
03/20/2003US20030054533 Novel expansin polynucleotides, related polypeptides and methods of use
03/20/2003US20030054525 UDP-N-acetylglucosamine: galactose-beta1,3-N-acetylgalactosamine-alpha-R / (GlcNAc to GalNAc) beta1,6-N-acetylglucosaminyltransferase, C2GnT3
03/20/2003US20030054524 Method of increasing the fatty acid content in plant seeds
03/20/2003US20030054523 Isoprenoid production
03/20/2003US20030054522 Nucleotide sequences for use as gene transfer tools in plants
03/20/2003US20030054521 Polynucleotide coding enzymatic polypeptide for use in generation of edible oil in plants and seeds
03/20/2003US20030054520 Recombinant enzymes having improved NAD (H) affinity
03/20/2003US20030054519 Pseudomonas microorganism for use in the generation of indigo
03/20/2003US20030054518 Novel xylanase from trichoderma reesei, method for production thereof, and methods employing this enzyme
03/20/2003US20030054517 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054516 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054513 Novel human enzymes and polynucleotides encoding the same
03/20/2003US20030054506 Method of producing L-lysine
03/20/2003US20030054505 Infectious Respiratory Syncytial Viral particle for use as gene transfer tool in genetic engineering
03/20/2003US20030054502 Generation of pantothenic acid and/or a salt; obtain microorganism coding pantothenic acid or salt, ferment and recover pantothenic acid or salt
03/20/2003US20030054498 Recombinant vector for use in gene therapy for insulin-dependent diabetes mellitus and therapeutic composition thereof
03/20/2003US20030054497 Increasing antibody affinity by altering glycosylation of immunoglobulin variable region
03/20/2003US20030054495 Chimaeric phage for use as tool in genetic engineering
03/20/2003US20030054494 Novel chimpanzee erythropoietin (CHEPO) polypeptides and nucleic acids encoding the same
03/20/2003US20030054492 Method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis
03/20/2003US20030054491 Peptide for use in the treatment of immunological, infectious and cancer disorders
1 ... 2564 2565 2566 2567 2568 2569 2570 2571 2572 2573 2574 2575 2576 2577 2578 2579 2580 2581 2582 2583 2584 ... 4023